AJP - Cell Physiology, Vol 254, Issue 1 C8-19, Copyright © 1988 by American Physiological Society

ARTICLES

Cultured bovine coronary arterial endothelial cells synthesize HETEs and prostacyclin

G. E. Revtyak, A. R. Johnson and W. B. Campbell
Department of Pharmacology, University of Texas Health Science Center, Dallas 75235.

Arachidonic acid metabolism was examined in endothelial cells cultured from bovine coronary arteries. In culture, these cells exhibit specific characteristics of endothelial cells. They form a contact-inhibited monolayer with a cobblestone appearance, contain immunoreactive von Willebrand's factor antigen, and have angiotensin I converting enzyme activity. Prostacyclin was the major prostaglandin synthesized from exogenous and endogenous arachidonic acid in these cells. In addition, exogenous arachidonic acid was metabolized to small amounts of prostaglandin E2 (PGE2) and several relatively nonpolar metabolites including 12-, 15-, and 11-hydroxyeicosatetraenoic acids (12-, 15-, and 11-HETE). Histamine, bradykinin, and thrombin increased PGI2 synthesis in these bovine coronary endothelial cells. Of these agonists, bradykinin was the most potent, increasing basal PGI2 release by fourfold. More vigorous stimulation of the cells with mechanical disruption of the cell monolayer, melittin, or A23187 resulted in release of both PGI2 and PGE2. Pretreatment of cells with exogenous arachidonic acid (10(-5) M) abolished their responsiveness to subsequent stimulation by arachidonic acid or vasoactive agents, but not PGH2. Furthermore, treatment of cells with 15-HPETE (10(-7)-10(-4) M), but not 15-HETE, specifically inhibited basal as well as A23187-stimulated PGI2 release. PGE2 release was increased slightly after 15-HPETE treatment. These studies indicate that bovine coronary endothelial cells can metabolize arachidonic acid to several biologically active products and that PGI2 synthesis by these cells is specifically related to the type of vasoactive agent employed. Both the qualitative pattern and quantity of eicosanoids synthesized by bovine coronary endothelial cells differ substantially from endothelial cells isolated from noncardiac vascular beds.

This article has been cited by other articles:

				K. Nithipatikom, P. F. Pratt, and W. B. Campbell Determination of EETs using microbore liquid chromatography with fluorescence detection Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H857 - H862. [Abstract] [Full Text] [PDF]

				E. R. Wohlfeil and W. B. Campbell 25-Hydroxycholesterol Increases Eicosanoids and Alters Morphology in Cultured Pulmonary Artery Smooth Muscle and Endothelial Cells Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2901 - 2908. [Abstract] [Full Text] [PDF]

				P.-L. Li, C.-L. Chen, R. Bortell, and W. B. Campbell 11,12-Epoxyeicosatrienoic Acid Stimulates Endogenous Mono-ADP-Ribosylation in Bovine Coronary Arterial Smooth Muscle Circ. Res., August 20, 1999; 85(4): 349 - 356. [Abstract] [Full Text] [PDF]

				P. F. Pratt, C. J. Hillard, W. S. Edgemond, and W. B. Campbell N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H375 - H381. [Abstract] [Full Text] [PDF]

				H. Kan, Y. Ruan, and K. U. Malik Signal Transduction Mechanism(s) Involved in Prostacyclin Production Elicited by Acetylcholine in Coronary Endothelial Cells of Rabbit Heart J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 113 - 122. [Abstract] [Full Text]

				Y. Ruan, H. Kan, and K. U. Malik J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1038 - 1046. [Abstract] [Full Text]

				P. F. Pratt, M. Rosolowsky, and W. B. Campbell Mediators of Arachidonic Acid–Induced Relaxation of Bovine Coronary Artery Hypertension, July 1, 1996; 28(1): 76 - 82. [Abstract] [Full Text]

				R. A. Cohen and P. M. Vanhoutte Endothelium-Dependent Hyperpolarization : Beyond Nitric Oxide and Cyclic GMP Circulation, December 1, 1995; 92(11): 3337 - 3349. [Full Text]